In the late stages of disease, PD-L1 was detected on cancer cells and immune cells, including CD4+ T cells (including Treg cells), CD3+CD8+ and CD3dimCD8dim T cells, natural killer (NK) cells, myeloid-derived suppressor cells, and alveolar macrophages. The gene discussed is CD8A; the disease is cancer.